Does Tracking Your Symptoms Actually Reduce Them? What the Research Says About Perimenopause and Menopause Symptom Tracking

By the Amsara Health team · Clinical review: Mia Chorney, DNP, MSCP · Updated October 2026

Most women arrive at a first menopause visit with a story and a feeling, and very little data. “I think the hot flashes are worse at night.” “My mood has been off for months, maybe longer.” It is not that the story is wrong; it is that memory flattens patterns, and a 20-minute appointment rarely has room to reconstruct six months of nights. The surprising finding from the last five years of research is that the act of writing symptoms down does more than prepare you for that appointment. It changes the symptoms.

Does tracking symptoms actually reduce them?

Yes, and the strongest evidence is a randomized controlled trial published in Menopause, the journal of The Menopause Society. Researchers at the University of South Wales randomized 100 perimenopausal and postmenopausal women (mean age 46) to either two weeks of daily symptom monitoring or a control condition. The monitoring group reported a 42% reduction in physical symptoms at follow-up versus 12% in the control group, and a significant reduction in negative emotions that the control group did not show. The effects survived adjustment for personality traits such as neuroticism, coping style, and medical and demographic differences (Andrews, John and Lancastle, Menopause 2023). The authors concluded that symptom monitoring offers “a simple and accessible means of symptom alleviation” while women wait for treatment or a consultation. One disclosure worth knowing: the lead author went on to work for a menopause app company, which is why we lean on the independent meta-analysis and the second trial below as well.

That trial grew out of the same group’s systematic review and meta-analysis of 18 studies and 1,718 participants, which found that monitoring was associated with improvements in menopausal symptoms, better patient-doctor communication and medical decision-making, heightened health awareness, and stronger engagement in setting treatment goals, with large pooled effects for prolonged symptom diaries on hot flash frequency (Andrews et al., Frontiers in Global Women’s Health 2021).

Why would writing a symptom down make it smaller?

Three mechanisms show up repeatedly in the research. The first is attention: monitoring converts a vague sense of being unwell into specific, bounded events with a start, a trigger, and an end, which lowers the emotional charge around them. The second is pattern recognition. In a 2025 qualitative study of women using menopause apps, participants described “being able to log symptoms and see patterns emerging,” realizing that symptoms they had dismissed were connected, and feeling they finally had “proof for the doctors” (Sillence et al., DIGITAL HEALTH 2025). The third is behavior: once you can see that the night sweats follow the second glass of wine, or that the brain fog clusters in the week before a period, you change something. The 2021 meta-analysis found exactly those downstream effects on help-seeking and decision-making.

The same qualitative study is honest about the limits, and so are we. A few women found that returning to an app repeatedly made them overthink new sensations, and the authors caution that tracking should not turn menopause into a numbers exercise. The goal is a clearer picture, not a second job.

What happens when tracking is built into a digital program?

Two further studies move from paper diaries to apps. In a longitudinal cohort of 1,900 women using a menopause app for two months, greater weekly engagement was associated with greater symptom reductions, and logging symptoms and menstrual periods were each independently associated with improvement, separate from the app’s other activities (Andrews et al., BMJ Open 2023). The study is observational and company-affiliated, so it shows association rather than cause, but the dose-response pattern is consistent with the randomized trial.

In a 2025 randomized controlled trial of 149 women aged 30 to 60 with bothersome hot flashes and at least one elevated distress measure, a self-guided app combining a daily symptom tracker with cognitive behavioral lessons, guided mindfulness, and peer community reduced hot flash distress by about 17% over six weeks against an education-only control (Hedges g = 0.64), with sleep improving by week three and depressive symptoms falling in the clinically depressed subgroup. Hot flash frequency did not change, which is a useful reminder: tracking and behavioral tools change how much symptoms interfere with life more reliably than they change the physiology underneath (Duffecy et al., JMIR mHealth and uHealth 2025). For the physiology, there is hormone therapy.

Harmoni: tracking built for perimenopause, now free

Amsara Health is the telehealth practice of The Pause Technologies, and our sister company’s app, Harmoni, is the tracking tool we recommend to patients. Harmoni is an AI companion trained on evidence-based menopause data. She tracks 27 common symptoms, including the neurological ones such as brain fog and dizziness that most trackers skip, along with sleep, habits, and periods. You can log by voice or text, or tell Siri on your iPhone, so there is no need to press buttons at 3 a.m. Harmoni connects to Apple Health and Fitbit for heart rate variability and sleep stages, and her Resilience Score gives you a baseline with or without a wearable.

The feature that matters most for your care is the trend report. At 30, 60, or 90 days Harmoni produces a downloadable summary of your symptoms and mood over time, with two interpretations: one written for you, and one written for your provider. That is the “proof for the doctors” the research describes, generated for you rather than assembled by hand. Bring it to your Amsara visit and your provider starts from your actual pattern instead of your best guess.

Harmoni launched a free version in October 2026. Tracking, the AI companion, and the core trend features are free; Harmoni Premium adds deeper analysis for $9.99 a month or $89.99 a year. The Pause Technologies was one of ten companies selected for the 2025 Mayo Clinic and ASU MedTech Accelerator, and Harmoni is clinician endorsed. To be clear about the evidence: the studies cited in this article are independent research on symptom monitoring and on other digital programs; they are not studies of Harmoni. What they establish is that the habit works. Harmoni is designed to make the habit effortless.

How to track so it actually helps

• Log daily for at least two weeks before a visit. The randomized trial saw its effect in 14 days; the cohort study saw larger gains with more weeks of consistent logging.
• Track the symptom, the time, and one context note. What you ate, how you slept, where you are in your cycle. Patterns live in the context.
• Include mood and the neurological symptoms. Negative emotions fell as much as physical symptoms in the trial, and brain fog, dizziness, and anxiety are among the most under-reported perimenopause symptoms.
• Review the trend, not the day. A single bad night is noise; three weeks of bad nights before your period is information.
• Bring the report to your provider. At Amsara, your initial visit is 60 minutes, and a 90-day trend report turns the first 20 of them from reconstruction into planning.

What tracking cannot do

Tracking is not treatment. The randomized trial reduced symptoms over two weeks; it did not restore estrogen, protect bone, or resolve severe vasomotor symptoms. For most healthy women within ten years of menopause, hormone therapy remains the most effective treatment for hot flashes and night sweats (The Menopause Society, 2022 position statement), and the FDA removed the boxed warnings from menopausal hormone therapy labels in late 2025. Non-hormonal medications such as Veozah and Lynkuet exist for women who cannot take estrogen. Tracking tells you and your provider what is happening; a provider decides what to do about it. Our page on hormone replacement therapy in Arizona covers who it is for, what we prescribe, and what it costs, and perimenopause care in Arizona covers the earlier years.

This article is for education and is not a substitute for individual medical advice. Talk with a licensed provider about your specific situation. Harmoni is a product of The Pause Technologies, the parent company of Amsara Health.

Frequently asked questions

---

Start tracking tonight. Bring the pattern to us.

Download Harmoni free, then book an unhurried visit with a provider who understands the hormone shift.

Already a patient? Share your Harmoni trend report with your care team through the Amsara Patient Portal.